The observation that L-dopa has no significant effect on the apparent incorporation of ~-[4,5-~H]lysine after a 7.5 min incorporation period, but produces a gross inhibition after a 15min period, is consistent with our conclusion that L-dopa has little effect on protein synthesis and also indicates that protein-bound lysine is derived from at least two separate pools, which equilibrate with plasma lysine at different rates.
There is strong evidence (for review, see Badawy, 1977) for an inverse relationship between liver tryptophan pyrrolase (EC 1.13.1 1.1 1) activity and brain 5-hydroxytryptamine concentration, synthesis or turnover. Pyrrolase activity could affect brain 5-hydroxytryptamine synthesis by a number of mechanisms, the most important of which is the altered availability of circulating tryptophan to the brain. Thus, pyrrolase enhancement by acute administration of cortisol (Green et al., 1975) or ethanol (Badawy & Evans, 1976) decreases the concentrations of liver, free and total serum (or plasma) and brain tryptophan and those of brain 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid. N o attempt has so far been made to examine the distribution of tryptophan between liver, serum and brain under conditions of inhibited tryptophan pyrrolase activity. The present communication reports such study in rats whose pyrrolase activity has been inhibited by chronic ethanol administration; this inhibition has been reported (Badawy & Evans, 1973a ,b, 1975 .
Male Wistar rats (205-2538, four per cage) were maintained on cube diet 41B. Ethanol was administered in drinking water (Badawy & Evans, 1973b) for 7 days. Tryptophan pyrrolase activity and the concentrations of liver, free (ultrafiltrable) serum, total (acid-soluble) serum and brain tryptophan and those of brain 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid were determined as described previously (Badawy & Evans, 1976) . The concentration of serum glucose was determined fluorimetrically (Slein, 1963) , whereas that of serum non-esterified fatty acids was determined by the method of Mikac-DeviC et al. (1973) , except that the two phases were separated by filtration through phase-separating, silicone-treated papers (Whatman no. IPS).
The results are shown in Table I . After 7 days of chronic ethanol administration, the total pyrrolase activity was decreased by 28% (P<O.Ool), whereas that of the 576th MEETING, LONDON holo-enzyme was not altered. The apo-enzyme (obtained by difference) was therefore the form specifically inhibited by ethanol (by 64%; P<0.025), thus confirming our previous findings (Badawy & Evans, 19736, 1975) . Under these conditions, liver tryptophan concentration was increased by ethanol by 18% (P<0.005) and this is consistent with the inhibition of liver tryptophan pyrrolase activity decreasing hepatic tryptophan catabolism.
Chronic ethanol administration also increased the concentrations of free and total serum tryptophan by 28 and 26% respectively (P = 0.05-0.001). The binding of tryptophan to serum proteins (expressed as percentage free tryptophan) was not altered, since the rises in both forms of tryptophan were similar. The concentrations of serum non-esterified fatty acids or glucose were not significantly altered by chronic ethanol administration (P>O.IOO). This suggests that chronic ethanol administration does not affect lipolysis and may possibly also exert no effect on insulin. It may therefore be suggested that the effects of ethanol on serum tryptophan concentrations are caused by the inhibition of liver tryptophan pyrrolase activity.
Chronic ethanol administration increased the concentrations of brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid by 31, 23 and 25 % respectively (P = 0.005-0.001). These changes are consistent with a n increased brain 5-hydroxytryptamine synthesis and turnover, and may be due to the increased availability of circulating tryptophan to the brain. The present findings are therefore consistent with the concept of inhibition of liver tryptophan pyrrolase activity decreasing hepatic tryptophan catabolism, thus diverting the circulating amino acid to the brain and enhancing brain 5-hydroxy- We have recently reported that the analgesics morphine and buprenorphine and the neuroleptic haloperidol exert some of their effects via dopaminergic systems in the rat brain (Cowan et al., 197Sa,b) . Thus morphine and buprenorphine in rats previously unilaterally lesioned with 6-hydroxydopamine (2,4,5-trihydroxyphenethylamine) in the nigrostriatal pathway both initiate circling in the same direction as (+)-amphetamine, whereas morphine, buprenorphine and haloperidol all inhibit apomorphine induced circling. The circling behaviour initiated by the analgesics and (+)-amphetamine was antagonized by the narcotic antagonist naloxone (P. W. Dettmar, A. Cowan & D. S.
Walter, unpublished observations), as 'was the inhibition of apomorphine-induced circling by the two analgesics, but not that of the neuroleptic haloperidol.
In an attempt to correlate these data with biochemical activity, these agents have been studied for their effects in the rat brain on the turnover rate of noradrenaline and dopamine (3,4-dihydroxyphenethylamine) and on the concentration of their major metabolites 3-methoxy-4-hydroxyphenylglycol and homovanillic acid.
The turnover rates were measured by following the decrease in noradrenaline and dopamine concentrations after the intraperitoneal administration of 320mg of a-methyl-p-tyrosine methyl ester hydrochloride/kg (Brodie et a[., 1966) . The concentrations of noradrenaline and dopamine were measured after their 0-methylation to normetanephrine and 3-methoxytyramine in the presence of S-adenosyl-~-[methyl-~H]methionine (Cuello et al., 1973) . 3-Methoxy-Chydroxyphenylglycol was measured by the method of Walter 8~ Shilcock (1977) and homovanillic acid by the method of Walter et al. (1978) .
Buprenorphine (O.l-lOmg/kg), morphine (3-30mg/kg) and haloperidol (0.03-1 mg/ kg) dosed subcutaneously, all caused increases in the rate of turnover of dopamine, whereas only morphine at 30mg/kg increased the noradrenaline turnover rate. At these doses, no changes in the steady-state concentrations of either noradrenaline or dopamine occurred.
(+)-Amphetamine dosed subcutaneously, however, significantly decreased both noradrenaline and dopamine steady-state brain concentrations, which was reflected in the apparent increase in turnover rates of these amines. It was interesting that a marked decrease in noradrenaline occurred at both lOmg/kg (25% P<0.05) and 30mg/kg (67% P<O.oOl), whereas 30mg/kg (28% P<O.OOl) had to be given to cause a decrease in the dopamine concentration.
We have reported elsewhere (Cowan et a[., 1976 ) that buprenorphine at some but not all doses and haloperidol cause increases in rat brain homovanillic acid concen-
